Mabylon
an innovator in the high-throughput discovery, characterisation, and development of human-derived antibodies
Zurich, Switzerlandwww.mabylon.com ↗
Total raised
€32M
€31,800,000
Funding rounds
1
Investors
1
distinct backers
Active since
2025-08
latest 2025-08
Funding by year
EUR raised per yearSignals
Medium confidenceRaise-next likelihood36
base rate 30% for Other
- ▲ In typical raise window
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-08-12 | Other | €32M | existing private investors | View deal → |
Investors
1Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Roivant Sciences€1.2BSwitzerland · Healthtech
- CMR Surgical€1.2BUK · Healthtech
- Climeworks€920MSwitzerland · Cleantech
- Energy Vault€896MSwitzerland · Energy